Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ulrike Uhrig

Showing results (11-20 of 14) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 14 results.
Hemasphere|August 7, 2024
A cellular reporter system to evaluate endogenous fetal hemoglobin induction and screen for therapeutic compoundsThijs C J Verheul, Nynke Gillemans, Kerstin Putzker, et al.
Journal of the American Chemical Society|October 6, 2022
Aza-SAHA Derivatives Are Selective Histone Deacetylase 10 Chemical Probes That Inhibit Polyamine Deacetylation and Phenocopy HDAC10 KnockoutRaphael R Steimbach, Corey J Herbst-Gervasoni, Severin Lechner, et al.
Redox Biology|March 23, 2023
Low level of antioxidant capacity biomarkers but not target overexpression predicts vulnerability to ROS-inducing drugsJana Samarin, Piotr Fabrowski, Roman Kurilov, et al.
Cell Reports|July 21, 2021
Degradation of CCNK/CDK12 is a druggable vulnerability of colorectal cancerSebastian M Dieter, Christine Siegl, Paula L Codó, et al.
Pageof 2

Showing results (11-20 of 14) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 14 results.
Hemasphere|August 7, 2024
A cellular reporter system to evaluate endogenous fetal hemoglobin induction and screen for therapeutic compoundsThijs C J Verheul, Nynke Gillemans, Kerstin Putzker, et al.
Journal of the American Chemical Society|October 6, 2022
Aza-SAHA Derivatives Are Selective Histone Deacetylase 10 Chemical Probes That Inhibit Polyamine Deacetylation and Phenocopy HDAC10 KnockoutRaphael R Steimbach, Corey J Herbst-Gervasoni, Severin Lechner, et al.
Redox Biology|March 23, 2023
Low level of antioxidant capacity biomarkers but not target overexpression predicts vulnerability to ROS-inducing drugsJana Samarin, Piotr Fabrowski, Roman Kurilov, et al.
Cell Reports|July 21, 2021
Degradation of CCNK/CDK12 is a druggable vulnerability of colorectal cancerSebastian M Dieter, Christine Siegl, Paula L Codó, et al.
Pageof 2